Company Overview and News

Rewardle Holdings Ltd to boost cash position for payments platform

Rewardle Holdings Ltd (ASX:RXH) is targeting an increase in cash reserves and is heading to market with a capital raising.

Jack Matthews new chair of MediaWorks

Financially stressed broadcaster MediaWorks will gain high-profile telecommunications entrepreneur Jack Matthews as its chairman from the end of next month.

MediaWorks appoints Jack Matthews as board chairman

Mr Matthews will take up the position at the end of September. He will take over from Rod McGeoch, who has been chairman since 2013.

Rewardle Holdings Ltd to conduct institutional and retail raise

Rewardle Holdings Ltd (ASX:RXH) is preparing to outline details of a institutional and retail capital raising, with the ASX granting the company a trading halt to prepare. Rewardle has a proprietary technology platform to manage marketing and customer relationships. The halt will remain in place until the opening of trade on Thursday 11th August 2016, or earlier if an announcement is made to the market.

Appendix 4C - quarterly


Brand Partnership Update


R&D Tax refund received


Bannerman Resources Limited: Appointment of Managing Director/CEO

2016-03-09 marketwired
PERTH, AUSTRALIA--(Marketwired - March 9, 2016) - Bannerman Resources Limited (ASX:BMN)(TSX:BAN)(NAMIBIAN:BMN) Bannerman" or "the Company") is pleased to announce the appointment of Mr Brandon Munro as Managing Director and Chief Executive Officer. Mr Munro succeeds Mr Len Jubber, who has resigned to pursue other business interests. Mr Munro's appointment is...

Bannerman Resources Ltd CEO steps down

Bannerman Resources Ltd's (ASX:BMN; TSX:BAN; NSX:BMN) flagship asset is its 100% interest in the Etango Uranium Project, located in Namibia.

Half Yearly Report and Accounts


Appendix 4C - quarterly


Di Bella Coffee joins Rewardle


Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...